Stock Price
10.76
Daily Change
0.28%
Monthly
-49.32%
Yearly
-75.11%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Agios Pharmaceuticals 37.25 -0.12 -0.32% -18.42%
Applied Genetic Technologies 2.44 0.05 2.09% -43.26%
Alnylam Pharmaceuticals 188.80 1.65 0.88% 50.50%
Alexion Pharmaceuticals 182.50 0 0% 70.54%
Amgen 203.97 -0.56 -0.27% -7.42%
Arrowhead Research 74.04 3.15 4.44% 29.85%
Avrobio Inc 4.38 -0.08 -1.79% -68.78%
Biogen 250.13 -4.02 -1.58% 3.47%
Bluebird Bio 10.76 0.03 0.28% -75.11%
BioMarin Pharmaceutical 89.57 -0.22 -0.25% 14.61%
Dicerna Pharmaceuticals 38.00 0.02 0.05% 62.60%
Gilead Sciences 70.07 -0.56 -0.79% 17.76%
Intercept Pharmaceuticals 17.75 0.48 2.78% -52.53%
Immunogen 4.92 -0.08 -1.60% -7.17%
Incyte Corp 66.74 2.93 4.59% -17.77%
Ionis Pharmaceuticals 29.76 -0.57 -1.88% -40.53%
Moderna Inc 273.39 -2.99 -1.08% 150.40%
Mirati Therapeutics 141.20 3.39 2.46% -37.37%
Nektar Therapeutics 11.62 0.21 1.84% -29.49%
Novartis 76.56 0.01 0.01% -5.78%
Pfizer 50.89 -0.19 -0.37% 39.31%
PTC Therapeutics 39.41 -0.40 -1.00% -37.97%
Ultragenyx Pharmaceutical 77.58 0.58 0.75% -35.26%
Regeneron Pharmaceuticals 648.18 -1.14 -0.18% 27.52%
Seattle Genetics 173.20 -0.62 -0.36% 4.68%
Sangamo BioSciences 8.94 0.01 0.11% -8.50%
Sarepta Therapeutics 80.98 1.65 2.08% -40.33%
Vertex Pharmaceuticals 186.24 -0.61 -0.33% -14.61%
Acceleron Pharma 178.75 -0.93 -0.52% 57.43%

Indexes Price Day Year
US2000 2331 3.60 0.15% 26.36%
NASDAQ 15845 70.09 0.44% 31.01%

Bluebird Bio
bluebird bio, Inc. is a biotechnology company. The Company focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases and cancer. It develops LentiGlobin for sickle cell disease (SCD) as a one-time treatment for patients with SCD, a hereditary blood disorder resulting from a mutation in the ß-globin gene that causes polymerization of hemoglobin proteins, resulting in abnormal red blood cell function. It builds an integrated product platform with therapeutic in a variety of indications based on its lentiviral gene addition platform, gene editing and cancer immunotherapy capabilities. Its programs in genetic disease include betibeglogene autotemcel; LentiGlobin gene therapy for sickle cell disease (SCD); and elivaldogene autotemcel. Its programs in oncology are focused on developing novel T cell-based immunotherapies, including chimeric antigen receptor (CAR) and T cell receptor (TCR) T cell therapies.